Evidence map›Paper›PMID 26077073›Full record

ArticleIntensive care medicine2015

Resuscitation fluid use in Australian and New Zealand Intensive Care Units between 2007 and 2013.

N E Hammond, C Taylor, M Saxena, B Liu, S Finfer, P Glass, I Seppelt, L Willenberg, J Myburgh

Abstract read
PubMed Publisher
In one paragraph

Article in Intensive care medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Science-based fluid therapy in the intensive care unit: Professor Rinaldo Bellomo's legacy.Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine · 2025
    Review
  4. Article
  5. Violence in intensive care: a point prevalence study.Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine · 2022
    Article
  6. Article
  7. Balanced Crystalloid Solutions.American journal of respiratory and critical care medicine · 2019
    Review
  8. Resuscitation fluids.Current opinion in critical care · 2018
    Review
  9. Review
  10. Focus on fluid therapy.Intensive care medicine · 2017
    Article
  11. Article
  12. Fluid management in acute kidney injury.Intensive care medicine · 2017
    Review
  13. Review
  14. Article
  15. Article
  16. What's new on balanced crystalloid solutions?Intensive care medicine · 2016
    Article
  17. Article
  18. Article
  19. Focus on acute kidney injury and fluids.Intensive care medicine · 2016
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

N E HammondDivision of Critical Care and Trauma, The George Institute for Global Health, University of Sydney, Sydney, Australia, nhammond@georgeinstitute.org.au.
C Taylor
M Saxena
B Liu
S Finfer
P Glass
I Seppelt
L Willenberg
J Myburgh

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionRecent evidence indicates that the choice of intravenous fluids may affect outcomes in critically ill patients.

methodsWe recorded the administration of resuscitation fluids in patients admitted to Australian and New Zealand adult intensive care units (ICUs) for a 24-h period at 6 time points between 2007 and 2013. Changes in patterns of fluid use over this period were determined using regression analyses.

resultsOf the 2825 patients admitted to the 61 ICUs on the 6 study days, 754 (26.7%) patients received fluid resuscitation. Of those receiving fluid resuscitation, the proportion of patients receiving crystalloid significantly increased from 28.9% (41/142) in 2007 to 50.5% (48/95) in 2013 (adjusted odds ratio (OR) 2.93; 95% confidence intervals (CI) 1.35-6.33; p = 0.006); of these, the proportion of patients receiving buffered salt solutions significantly increased from 4.9% (7/142) in 2007 to 31.6% (30/95) in 2013 (OR 7.00; 95% CI 2.14-22.92; p = 0.001). The use of colloids significantly decreased from 59.9% (85/142) in 2007 to 42.1% (40/95) in 2013 (adjusted OR 0.34; 95% CI 0.16-0.74; p = 0.007) due to a significant decrease in the proportion of patients receiving gelatin; 28.9% (41/142) to 2.1% (2/95) (OR 0.10; 95% CI 0.03-0.29; p ≤ 0.001).

conclusionFluid resuscitation practice in Australia and New Zealand adult ICUs has changed over the 6-year study period. Crystalloid use increased primarily due to an increase in the use of buffered salt solutions while overall the use of colloid has decreased.

Indexed as

Fluid TherapyAustraliaColloidsCross-Sectional StudiesCrystalloid SolutionsFemaleHumansIntensive Care UnitsIsotonic SolutionsMaleMiddle AgedNew ZealandRehydration SolutionsResuscitationTime FactorsColloidsCrystalloid SolutionsIsotonic SolutionsRehydration Solutions

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.